Genki Sato

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Cross Sectional

Metabolic Syndrome

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Genki Sato, Hiroshi Uchino, Takahisa Hirose
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)